Blood Test
Blood test may improve detection of early pancreatic cancer
A novel evaluation of biomarkers known to be associated with pancreatic cancer significantly improved detection of early-stage disease compared with previous tests, according to results of a double-blind phase 2 trial.
Colonoscopy, stool-based screening outperforms blood test for colorectal cancer detection
Both colonoscopies and stool-based tests for colorectal cancer screening may be more efficient and cost-effective compared with blood-based tests, study findings published in Annals of Internal Medicine showed.
Q&A: Adults may know their risk for COPD with blood test
Adults may soon have an easy way to know whether they face a heightened risk for COPD and death due to a respiratory disease with the creation of a preclinical blood test that assesses 32 proteins, according to a press release.
Blood test may predict severe preeclampsia risk for women in labor
A blood test to measure fibrinogen-to-albumin ratio predicted preeclampsia and severe preeclampsia risk in laboring women compared with other blood markers, potentially providing a useful tool for anesthesiologists, researchers reported.
False-positive Shield test ‘does not appear’ to correlate with higher non-CRC cancer risk
PHILADELPHIA — Patients with a false-positive Shield test result did not appear to be at increased risk for non-colorectal cancer malignancies at 1 year compared with those with a true-negative result, according to a presenter here.
Researchers identify blood biomarkers for early detection, monitoring of AMD
A biomarker panel of three serum metabolites associated with the onset, severity and progression of age-related macular degeneration may aid in earlier detection and monitoring of disease, according to researchers.
Q&A: Rapid blood test could detect ALS within 2 days
A progressive neurodegenerative condition, ALS has no cure, with diagnosis often a result of protracted clinical evaluation that may take more than a year to accurately determine.
Blood test may predict response to CAR T-cell therapy in relapsed multiple myeloma
A simple blood test that measures lymphocyte count may accurately predict response to chimeric antigen receptor T-cell therapy among patients with relapsed multiple myeloma, according to study results.
Diagnostic firm receives $7 million to advance novel Alzheimer’s biomarker platform
C2N Diagnostics has been awarded more than $7 million from the Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator initiative to advance a novel platform intended to boost Alzheimer’s disease biomarker detection.
Q&A: 'Convenience is a major selling point' for new colorectal cancer blood test
The new blood test screening option for colorectal cancer is innovative and could improve screening uptake, but it also has some drawbacks, according to an expert.